192 related articles for article (PubMed ID: 17824841)
1. Hetero-oligomerization of the P2Y11 receptor with the P2Y1 receptor controls the internalization and ligand selectivity of the P2Y11 receptor.
Ecke D; Hanck T; Tulapurkar ME; Schäfer R; Kassack M; Stricker R; Reiser G
Biochem J; 2008 Jan; 409(1):107-16. PubMed ID: 17824841
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological profiles of cloned mammalian P2Y-receptor subtypes.
von Kügelgen I
Pharmacol Ther; 2006 Jun; 110(3):415-32. PubMed ID: 16257449
[TBL] [Abstract][Full Text] [Related]
3. Alanine-(87)-threonine polymorphism impairs signaling and internalization of the human P2Y11 receptor, when co-expressed with the P2Y1 receptor.
Haas M; Shaaban A; Reiser G
J Neurochem; 2014 May; 129(4):602-13. PubMed ID: 24524250
[TBL] [Abstract][Full Text] [Related]
4. Opposite diastereoselective activation of P2Y1 and P2Y11 nucleotide receptors by adenosine 5'-O-(alpha-boranotriphosphate) analogues.
Ecke D; Tulapurkar ME; Nahum V; Fischer B; Reiser G
Br J Pharmacol; 2006 Oct; 149(4):416-23. PubMed ID: 16953187
[TBL] [Abstract][Full Text] [Related]
5. Subtype specific internalization of P2Y1 and P2Y2 receptors induced by novel adenosine 5'-O-(1-boranotriphosphate) derivatives.
Tulapurkar ME; Laubinger W; Nahum V; Fischer B; Reiser G
Br J Pharmacol; 2004 Jul; 142(5):869-78. PubMed ID: 15197109
[TBL] [Abstract][Full Text] [Related]
6. P2Y1-receptors in human platelets which are pharmacologically distinct from P2Y(ADP)-receptors.
Fagura MS; Dainty IA; McKay GD; Kirk IP; Humphries RG; Robertson MJ; Dougall IG; Leff P
Br J Pharmacol; 1998 May; 124(1):157-64. PubMed ID: 9630355
[TBL] [Abstract][Full Text] [Related]
7. P2Y receptors: biological advances and therapeutic opportunities.
Shaver SR
Curr Opin Drug Discov Devel; 2001 Sep; 4(5):665-70. PubMed ID: 12825461
[TBL] [Abstract][Full Text] [Related]
8. Agonist action of adenosine triphosphates at the human P2Y1 receptor.
Palmer RK; Boyer JL; Schachter JB; Nicholas RA; Harden TK
Mol Pharmacol; 1998 Dec; 54(6):1118-23. PubMed ID: 9855642
[TBL] [Abstract][Full Text] [Related]
9. Identification of competitive antagonists of the P2Y1 receptor.
Boyer JL; Romero-Avila T; Schachter JB; Harden TK
Mol Pharmacol; 1996 Nov; 50(5):1323-9. PubMed ID: 8913364
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a Ca2+ response to both UTP and ATP at human P2Y11 receptors: evidence for agonist-specific signaling.
White PJ; Webb TE; Boarder MR
Mol Pharmacol; 2003 Jun; 63(6):1356-63. PubMed ID: 12761346
[TBL] [Abstract][Full Text] [Related]
11. NF546 [4,4'-(carbonylbis(imino-3,1-phenylene-carbonylimino-3,1-(4-methyl-phenylene)-carbonylimino))-bis(1,3-xylene-alpha,alpha'-diphosphonic acid) tetrasodium salt] is a non-nucleotide P2Y11 agonist and stimulates release of interleukin-8 from human monocyte-derived dendritic cells.
Meis S; Hamacher A; Hongwiset D; Marzian C; Wiese M; Eckstein N; Royer HD; Communi D; Boeynaems JM; Hausmann R; Schmalzing G; Kassack MU
J Pharmacol Exp Ther; 2010 Jan; 332(1):238-47. PubMed ID: 19815812
[TBL] [Abstract][Full Text] [Related]
12. Functional distribution of Ca2+-coupled P2 purinergic receptors among adrenergic and noradrenergic bovine adrenal chromaffin cells.
Tomé AR; Castro E; Santos RM; Rosário LM
BMC Neurosci; 2007 Jun; 8():39. PubMed ID: 17570839
[TBL] [Abstract][Full Text] [Related]
13. P2 receptor mRNA expression profiles in human lymphocytes, monocytes and CD34+ stem and progenitor cells.
Wang L; Jacobsen SE; Bengtsson A; Erlinge D
BMC Immunol; 2004 Aug; 5():16. PubMed ID: 15291969
[TBL] [Abstract][Full Text] [Related]
14. P2Y receptor expression on astrocytes in the nucleus accumbens of rats.
Franke H; Krügel U; Grosche J; Heine C; Härtig W; Allgaier C; Illes P
Neuroscience; 2004; 127(2):431-41. PubMed ID: 15262333
[TBL] [Abstract][Full Text] [Related]
15. Expression of P2 receptors in human B cells and Epstein-Barr virus-transformed lymphoblastoid cell lines.
Lee DH; Park KS; Kong ID; Kim JW; Han BG
BMC Immunol; 2006 Sep; 7():22. PubMed ID: 16970829
[TBL] [Abstract][Full Text] [Related]
16. P2X and P2Y purinergic receptors on human intestinal epithelial carcinoma cells: effects of extracellular nucleotides on apoptosis and cell proliferation.
Coutinho-Silva R; Stahl L; Cheung KK; de Campos NE; de Oliveira Souza C; Ojcius DM; Burnstock G
Am J Physiol Gastrointest Liver Physiol; 2005 May; 288(5):G1024-35. PubMed ID: 15662049
[TBL] [Abstract][Full Text] [Related]
17. Fidelity in functional coupling of the rat P2Y1 receptor to phospholipase C.
Schachter JB; Boyer JL; Li Q; Nicholas RA; Harden TK
Br J Pharmacol; 1997 Nov; 122(6):1021-4. PubMed ID: 9401764
[TBL] [Abstract][Full Text] [Related]
18. Molecular pharmacology of P2Y-receptors.
von Kügelgen I; Wetter A
Naunyn Schmiedebergs Arch Pharmacol; 2000 Nov; 362(4-5):310-23. PubMed ID: 11111826
[TBL] [Abstract][Full Text] [Related]
19. Distinct roles for protein kinase C isoforms in regulating platelet purinergic receptor function.
Mundell SJ; Jones ML; Hardy AR; Barton JF; Beaucourt SM; Conley PB; Poole AW
Mol Pharmacol; 2006 Sep; 70(3):1132-42. PubMed ID: 16804093
[TBL] [Abstract][Full Text] [Related]
20. Internalization and desensitization of a green fluorescent protein-tagged P2Y nucleotide receptor are differently controlled by inhibition of calmodulin-dependent protein kinase II.
Tulapurkar ME; Zündorf G; Reiser G
J Neurochem; 2006 Feb; 96(3):624-34. PubMed ID: 16405509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
